Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
American Journal of Respiratory and Critical Care Medicine|January 13, 2018
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated EffectsDaniel Ajona, Carolina Zandueta, Leticia Corrales, et al.Scientific Reports|October 30, 2019
Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1Maria Villalba, Esther Redin, Francisco Exposito, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2022
YES1 Is a Druggable Oncogenic Target in SCLCEsther Redin, Eva M Garrido-Martin, Karmele Valencia, et al.The Journal of Investigative Dermatology|September 4, 2022
The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in MelanomaIrene Lasheras-Otero, Iker Feliu, Alberto Maillo, et al.Molecular Therapy. Nucleic Acids|August 31, 2023
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonistsAssunta Cirella, Elixabet Bolaños, Carlos Luri-Rey, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 17, 2014
The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activityNaiara Martinez-Velez, Enric Xipell, Patricia Jauregui, et al.Bioengineering & Translational Medicine|September 30, 2022
Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in bloodAlejandro Rodríguez-Pena, Estibaliz Armendariz, Alvaro Oyarbide, et al.Journal for Immunotherapy of Cancer|August 24, 2022
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancerMyrto K Moutafi, Magdalena Molero, Sandra Martinez Morilla, et al.Journal of the National Cancer Institute|June 27, 2023
Circulating proteome for pulmonary nodule malignancyElham Khodayari Moez, Matthew T Warkentin, Yonathan Brhane, et al.Journal of the National Cancer Institute|April 22, 2015
Germline TP53 variants and susceptibility to osteosarcomaLisa Mirabello, Meredith Yeager, Phuong L Mai, et al.Pageof 10